Caption Management, LLC Uro Gen Pharma Ltd. Transaction History
Caption Management, LLC
- $8.03 Billion
- Q2 2025
A detailed history of Caption Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Caption Management, LLC holds 50,000 shares of URGN stock, worth $872,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$872,000% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding URGN
# of Institutions
161Shares Held
39.6MCall Options Held
2.06MPut Options Held
717K-
Rtw Investments, LP New York, NY4.54MShares$79.2 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$55.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$43.2 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$38.4 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$38.3 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $397M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...